Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

8,128 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Impact of donor types on reduced-intensity conditioning allogeneic stem cell transplant for mature lymphoid malignancies.
Imahashi N, Terakura S, Kondo E, Kato K, Kim SW, Shinohara A, Watanabe M, Fukuda T, Uchida N, Kobayashi H, Ishikawa J, Kataoka K, Shiratori S, Ikeda T, Matsuoka KI, Yoshida S, Kondo T, Kimura T, Onizuka M, Ichinohe T, Atsuta Y, Kanda J. Imahashi N, et al. Among authors: yoshida s. Bone Marrow Transplant. 2022 Feb;57(2):243-251. doi: 10.1038/s41409-021-01525-1. Epub 2021 Nov 24. Bone Marrow Transplant. 2022. PMID: 34815519
Successful Secondary Umbilical Cord Blood Transplantation for Graft Failure in Acute Myelogenous Leukemia, Treated with Modified One-Day Conditioning Regimen, and Graft-Versus-Host Disease Prophylaxis Consisting of Mycophenolate and Tacrolimus.
Kawano N, Kuriyama T, Yoshida S, Shimizu I, Kobayashi H, Takenaka K, Uchida N, Takami A, Yamashita K, Ueda A, Kikuchi I. Kawano N, et al. Among authors: yoshida s. J Clin Exp Hematop. 2015;55(2):89-96. doi: 10.3960/jslrt.55.89. J Clin Exp Hematop. 2015. PMID: 26490521 Free article.
Mogamulizumab Treatment Prior to Allogeneic Hematopoietic Stem Cell Transplantation Induces Severe Acute Graft-versus-Host Disease.
Sugio T, Kato K, Aoki T, Ohta T, Saito N, Yoshida S, Kawano I, Henzan H, Kadowaki M, Takase K, Muta T, Miyawaki K, Yamauchi T, Shima T, Takashima S, Mori Y, Yoshimoto G, Kamezaki K, Takenaka K, Iwasaki H, Ogawa R, Ohno Y, Eto T, Kamimura T, Miyamoto T, Akashi K. Sugio T, et al. Among authors: yoshida s. Biol Blood Marrow Transplant. 2016 Sep;22(9):1608-1614. doi: 10.1016/j.bbmt.2016.05.017. Epub 2016 May 21. Biol Blood Marrow Transplant. 2016. PMID: 27220263 Free article.
The impact of hepatitis B core antibody levels on HBV reactivation after allogeneic hematopoietic SCT: an 11-year experience at a single center.
Bae SK, Gushima T, Saito N, Yamanaka I, Shimokawa T, Matsuo Y, Yoshida S, Kawano I, Henzan H, Shimoda S, Eto T, Takahashi K. Bae SK, et al. Among authors: yoshida s. Bone Marrow Transplant. 2016 Nov;51(11):1496-1498. doi: 10.1038/bmt.2016.149. Epub 2016 Jun 6. Bone Marrow Transplant. 2016. PMID: 27272453 No abstract available.
Comparison of cyclosporine and tacrolimus combined with mycophenolate mofetil in prophylaxis for graft-versus-host disease after reduced-intensity umbilical cord blood transplantation.
Miyamoto T, Takashima S, Kato K, Takase K, Yoshimoto G, Yoshida S, Henzan H, Osaki K, Kamimura T, Iwasaki H, Eto T, Teshima T, Nagafuji K, Akashi K. Miyamoto T, et al. Among authors: yoshida s. Int J Hematol. 2017 Jan;105(1):92-99. doi: 10.1007/s12185-016-2093-0. Epub 2016 Sep 29. Int J Hematol. 2017. PMID: 27686673
Increased non-relapse mortality due to high-dose cytarabine plus CY/TBI in BMT/PBSCT for acute lymphoblastic leukaemia in adults.
Arai Y, Kondo T, Shigematsu A, Tanaka J, Ohashi K, Fukuda T, Kawakita T, Mori T, Hoshino T, Onizuka M, Ozawa Y, Yoshida S, Ueda Y, Mizuno I, Atsuta Y, Mizuta S; Japan Society for Haematopoietic Cell Transplantation. Arai Y, et al. Among authors: yoshida s. Br J Haematol. 2017 Jul;178(1):106-111. doi: 10.1111/bjh.14652. Epub 2017 Apr 25. Br J Haematol. 2017. PMID: 28439877 Free article.
HBV reactivation after hematopoietic stem cell transplantation and rituximab-containing chemotherapy: a 12-year experience at a single center.
Bae SK, Gushima T, Saito N, Yamanaka I, Matsuo Y, Yoshida S, Kawano I, Henzan H, Shimoda S, Eto T, Takahashi K. Bae SK, et al. Among authors: yoshida s. Bone Marrow Transplant. 2019 Apr;54(4):629-631. doi: 10.1038/s41409-018-0355-6. Epub 2018 Oct 4. Bone Marrow Transplant. 2019. PMID: 30287937 No abstract available.
Safety and Seropositivity after Live Attenuated Vaccine in Adult Patients Receiving Hematopoietic Stem Cell Transplantation.
Aoki T, Kamimura T, Yoshida S, Mori Y, Kadowaki M, Kohno K, Ishihara D, Urata S, Sugio T, Kamezaki K, Kato K, Ito Y, Eto T, Akashi K, Miyamoto T. Aoki T, et al. Among authors: yoshida s. Biol Blood Marrow Transplant. 2019 Aug;25(8):1576-1585. doi: 10.1016/j.bbmt.2019.04.006. Epub 2019 Apr 6. Biol Blood Marrow Transplant. 2019. PMID: 30959161 Free article. Clinical Trial.
8,128 results